The Juliet Keidan Institute of Pediatric Gastroenterology Institute, Shaare Zedek Medical Center, Jerusalem 9103102, Israel.
Centeral Virology Laboratory, Israeli Ministry of Health, Sheba Medical Center, Ramat-Gan 52620000, Israel.
Viruses. 2024 May 20;16(5):808. doi: 10.3390/v16050808.
An increase in the number of cases of acute hepatitis of unknown origin (HUO) in children was observed in 2021. Adenovirus and adeno-associated virus 2 (AAV2) infections have been suggested as possible triggers. However, the potential etiology is still unclear. We aimed to characterize a cohort of children with HUO in Israel in view of the COVID-19 pandemic.
Demographics, clinical data, and laboratory results on the children compatible with the CDC criteria for HUO were collected by the established registry of the Ministry of Health. Available specimens were sent to the Central Virology Laboratory.
A total of 39 children were included in the registry. A total of 20 were enrolled prospectively, in which human herpes virus 6 (HHV6) infection or reactivation was identified in 11/19, adenovirus was found in 4/19 of the cases, and AAV2 was detected in 2/16. Past COVID-19 exposure was recorded for 24/39 of the children. A total of 10 children underwent liver biopsy, and 8 were successfully treated with steroids and 2 underwent liver transplantation.
The COVID-19 pandemic and the related containment measures combined with reactivation or active infection with other viruses could have been a trigger for the HUO outbreak. In our cohort, HHV6 was the most abundant finding.
2021 年观察到儿童不明来源急性肝炎(HUO)病例数增加。腺病毒和腺相关病毒 2(AAV2)感染被认为是可能的诱因。然而,潜在病因仍不清楚。鉴于 COVID-19 大流行,我们旨在描述以色列一组 HUO 儿童的特征。
通过卫生部建立的登记处收集符合疾病预防控制中心 HUO 标准的儿童的人口统计学、临床数据和实验室结果。将可用标本送到中央病毒学实验室。
该登记处共纳入 39 名儿童。共有 20 名儿童前瞻性入组,其中 19 例中发现人类疱疹病毒 6(HHV6)感染或再激活,19 例中发现腺病毒,16 例中发现 AAV2。39 例儿童中有 24 例有过去 COVID-19 接触史。共有 10 名儿童接受了肝活检,8 名成功接受了类固醇治疗,2 名接受了肝移植。
COVID-19 大流行和相关的遏制措施加上其他病毒的再激活或活跃感染可能是 HUO 爆发的诱因。在我们的队列中,HHV6 是最常见的发现。